Form D · Pharmaceuticals
AVANTI PHARMA CORP
Boca Raton, FL · CIK 0001467575
Offering snapshot reported Jul 16, 2009 · SEC filing
- Reported sold
- $350K Offering amount: $4M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jul 2, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2009 | Initial | $350,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 46
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-132837
Source: Form D, filed Jul 16, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Desica | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
7900 Glades Road #500
Boca Raton, FL, 33434
Boca Raton, FL, 33434